Gabelli Funds’s Cidara Therapeutics CDTX Stock Holding History

Gabelli Funds’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-148,666	Closed	-$32.8M	–	1276
2025 Q4	$32.8M	Buy	+148,666	New	+$24M	0.22%	116

Gabelli Funds's CDTX Position: Q1 2026 in Review

Gabelli Funds sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 148,666 shares — an estimated $32.8M sold.

Gabelli Funds first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $32.8M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Gabelli Funds reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Gabelli Funds sold 148,666 Cidara Therapeutics shares in Q1 2026, an estimated $32.8M.
Gabelli Funds first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Gabelli Funds's Cidara Therapeutics position peaked at $32.8M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.